Last Updated: September 24, 2026

Kalvista Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for KALVISTA

KALVISTA has one approved drug.

There are eight US patents protecting KALVISTA drugs.

Summary for Kalvista

US Patents:	8
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Kalvista

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kalvista	EKTERLY	sebetralstat	TABLET;ORAL	219301-001	Jul 3, 2025		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Kalvista	EKTERLY	sebetralstat	TABLET;ORAL	219301-001	Jul 3, 2025		RX	Yes	Yes	11,230,537	⤷ Start Trial	Y	Y		⤷ Start Trial
Kalvista	EKTERLY	sebetralstat	TABLET;ORAL	219301-001	Jul 3, 2025		RX	Yes	Yes	11,234,939	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Kalvista Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Slovenia	3716952	⤷ Start Trial
Moldova, Republic of	3567037	⤷ Start Trial
United Kingdom	201421083	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Kalvista Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3224256	202640002	Slovenia	⤷ Start Trial	PRODUCT NAME: SEBETRALSTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/25/1975; DATE OF NATIONAL AUTHORISATION: 20250917; AUTHORITY FOR NATIONAL AUTHORISATION: EU
3224256	PA2026502	Lithuania	⤷ Start Trial	PRODUCT NAME: SEBETRALSTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ARBASOLVATAS; REGISTRATION NO/DATE: EU/1/25/1975 20250917
3224256	CR 2026 00001	Denmark	⤷ Start Trial	PRODUCT NAME: SEBETRALSTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/25/1975 20250918
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Kalvista

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.